Instituto Di Ricovero E Cura A Carattere Scientifico

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Alzheimer disease1 trial
• Frontotemporal dementia1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Completed2 trials

Lead sponsor

• AbbVie1 trial
• Alector LLC1 trial

Closed trials

• Completed

  A Study to Assess Safety of ABBV-916 and How Intravenous ABBV-916 Moves Through Body and Affects Brain Amyloid Plaque Clearance in Adult Participants (Aged 50-90 Years) With Early Alzheimer's Disease

  NCT05291234· Phase 2· AbbVie· Source

• Completed

  A Phase 3 Study to Evaluate Efficacy and Safety of AL001 in Frontotemporal Dementia (INFRONT-3)

  NCT04374136· Phase 3· Alector LLC· Source